Yahoo Finance 
Yahoo Finance Plus Eurozone Inflation Eased in November, but Further Rate Rises Likely
Consumer prices in November were 10% higher than a year earlier but down from the 10.6% annual rate of inflation recorded in October as energy prices fell.
Consumer prices in November were 10% higher than a year earlier but down from the 10.6% annual rate of inflation recorded in October as energy prices fell.
Shares of Eli Lilly (NYSE: LLY) are tumbling Thursday morning. Ahead of the opening bell, Lilly announced its 2022 fourth-quarter financial results. Thanks to high expectations for newer growth products like Mounjaro and the steady progress of top clinical assets like Alzheimer's treatment donanemab, investors bid up the big pharma stock by a whopping 32.4% over the course of 2022.
Investors got a reminder of the capabilities of Palantir Technologies' (NYSE: PLTR) products, helping to reinforce the bull case for the stock. Palantir came to market in late 2020 to great enthusiasm, based largely on the reputation of its technology. The data-analytics provider is credited with helping the Pentagon find Osama bin Laden and with flagging the Bernie Madoff Ponzi scheme.
Shares of apparel company Hanesbrands (NYSE: HBI) dropped like a rock on Thursday after the company provided lackluster financial guidance and announced some substantial pivots to management's priorities. As of 11:40 a.m. ET, Hanesbrands stock was down 23% -- particularly painful, considering the market is soaring today. On one hand, fourth-quarter revenue of $1.47 billion beat guidance from Hanesbrands' management.
When Cathie Wood speaks, people listen. The chief executive of Ark Investment Management has had a far-from-perfect record when it comes to her investment choices -- not to mention not exactly flattering feedback from CNBC's Jim Cramer. When asked what stock Wood would choose she won a million dollar lottery and was forced to choose a stock for ten years, Wood's pick was just as disruptive as her reputation.
On any list of biotech plays that might multiply in value in a relatively short period, Cassava Sciences (NASDAQ: SAVA) is likely to be near the top of the list. It's exploring whether its drug called simufilam is safe and effective to treat early-stage Alzheimer's disease, though its clinical trials have (so far) shed little light on the issue. The biggest reason to sell Cassava stock: After an open-label phase 2 clinical trial of simufilam, the market reacted quite negatively to the release of new data that management spun as being positive.
The Nasdaq Composite dipped into a bear market last year, and the tech-heavy index is still 28% off its high. Investors often overreact to good and bad news, so stocks tend to rise too high during bull markets and fall too far during bear markets. Warren Buffett hinted at that quirk of human nature when he said, "Be fearful when others are greedy, and be greedy when others are fearful."
For the third day in a row, Tesla (NASDAQ: TSLA) stock is riding higher -- up 4.3% as of 10:10 a.m. ET. The Federal Reserve's decision to raise interest rates only 25 basis points yesterday is probably part of the reason for that -- indeed, growth stocks in general seem happy to run today, with the entire Nasdaq up nearly 2%. Tesla's plan to cut the prices of its electric cars, you see -- not just in the U.S., but in China as well -- is having its intended effect of stoking consumer demand.
Top health insurance company Humana (NYSE: HUM) wasn't necessarily tops with investors on Wednesday. After reporting its latest set of quarterly figures, the company's share price bumped slightly higher, by 0.3%, which wasn't high enough to beat the S&P 500 index's more than 1% increase. It's not that Humana's results for the fourth quarter 2022 were bad or uninspiring; it's just that they didn't excel.
A short squeeze occurs when short-sellers rush to cover their positions on a stock. The sudden rush of buying can quickly push a stock price higher. After a tough market year in 2022, some stocks have built up large short-seller followings, potentially priming the pump for a new wave of short squeezes.
Despite a dismal performance in 2022, shares of all-digital bank SoFi Technologies (NASDAQ: SOFI) climbed 50.3% in January. There are lots of reasons for the run-up, not least of which were a better-than-expected performance during the fourth quarter of 2022 and an improved outlook. Will the big gains SoFi made in January fizzle out in February, or is the stock at the beginning of a much longer bull run?
Yahoo Finance Live’s Julie Hyman breaks down oil earnings.
Change doesn't have to be bad.
Dividend stocks are a great way to mitigate downside risk, hedge against inflation, and generate reliable levels of passive income. Closed-end funds, real estate investment trusts (REITs), and some actively managed diversified holding companies are purpose-built to return an outsize portion of cash flows to shareholders via regular distributions. Arbor Realty Trust (NYSE: ABR) is a REIT with a current annualized yield of 10.75%.
Dividend investors should consider loading up on these stocks as this could be a good year for both of their businesses.
At this time, I'll now turn the conference over to Hooper Stevens, senior vice president of investor relations and finance. Today, we will have prepared remarks from Jennifer Witz, our chief executive officer; and Sean Sullivan, our chief financial officer.
Next-generation assisted-driving tech company MicroVision (NASDAQ: MVIS) had a macro Wednesday as far as its stock performance was concerned. The deal will allow MicroVision to integrate the privately held, Germany-based company's perception software features into its MicroVision ASIC assisted-driving system. At the time, the buyer wrote in a press release that "Together, MicroVision's MAVIN lidar hardware and Ibeo's mature software will position MicroVision as a leading hardware and perception software partner to [original equipment makers]."
Did you know that if a company were to increase its dividends by 5% per year, it would take 14 years for its payouts to double? A couple of stocks with the most aggressive dividend growth records you can invest in today are UnitedHealth Group (NYSE: UNH) and Broadcom (NASDAQ: AVGO). Health insurance giant UnitedHealth Group may not strike income investors as an ideal dividend stock to buy, as it yields just under 1.4%, which is below the S&P 500's current average yield of 1.7%.
In this article, we will 12 best discuss dividend growth stocks with 10% yearly increases. You can skip our detailed analysis of dividend companies and their returns over the years, and go directly to read 5 Best Dividend Growth Stocks With 10%+ Yearly Increases. The historical analysis of dividend growers has shown their outperformance over […]
Affirm Holdings (AFRM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Advanced Drainage (WMS) delivered earnings and revenue surprises of -4.81% and 6.26%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?